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A  number  of factors  have  been  implicated  in  positive  and  negative  feedback 
mechanisms regulating the production of granulocytes and macrophages in vitro and 
in vivo (1). A family of glycoproteins collectively termed colony-stimulating activity 
(CSA) 1 stimulates colony formation in vitro (1).  We have recently documented the 
existence  of a  negative  feedback control  mechanism  mediated  by  a  glycoprotein 
inhibitory factor derived from mature granulocytes which limits colony formation in 
vitro and  granulopoiesis  in  vivo by decreasing the production and  release of CSA 
from  normal  and  leukemic  monocytes  and  macrophages  (2-6).  From  our  recent 
interest in the postulated interaction of iron and iron-binding proteins with cells of 
the immune system (7, 8), we have noted that this colony inhibitory factor (CIF) is 
similar in  many respects to lactoferrin  (LF), the iron-binding protein first isolated 
from milk and also present in epithelial secretions and mature granulocytes (9-14). 
These include: (a) a similar biochemistry: CIF and LF are glycoproteins with mol wt 
"80-100,000  (6,  15)  and  isoelectric focus points of ~  pH 6.0-6.5  (6,  13,  16);  (b)  a 
similar site of production: both are found in mature granulocytes and are quantita- 
tively deficient in the mature granulocytes of  patients with acute and chronic leukemia 
and myelodysplasia (2, 3,  17-20); and (c) a similar site of action: both interact with 
monocytes and macrophages (2, 21, 22). In the present paper we identify CIF as LF 
and  present  evidence  that  strongly  implicates  LF  as  a  physiological  regulator  of 
granulopoiesis. 
Materials and Methods 
Physical Separation of Cells into Functional and Morphologic Populations.  Bone marrow and blood 
cells from healthy volunteers were separated on the basis of their density and/or adherence to 
plastic  surfaces  to obtain  populations of granulocyte and macrophage colony-forming  cells 
* Supported by Public Health Service  grants CA 23528, CA 17353, and CA 17085 from the National 
Cancer Institute, CA 05026 and CA 08748  from the National Institutes of Health, and by the Zelda R. 
Weintraub Foundation, the Lillia Babbitt Hyde Foundation, the H. Margolis Fund, and the Gar Reichman 
Foundation. 
:[: Scholar of the Leukemia Society of America. 
1 Abbreviations used in this paper: ApoLF, LF depleted of iron; BFU-e, erythroid burst-forming cell; CFU- 
c, granulocyte and macrophage colony-forming cell; CFU-e, erythroid colony-forming cell; CIF, inhibitor 
of CSA production; CSA, granulocyte and macrophage colony-stimulating activity; FCS, fetal calf serum; 
LF, lactoferrin; LIA, leukemia-associated inhibitory activity; LPS, bacterial lipopolysaccharide; native LF, 
LF saturated with ~8% iron; NIA, neutrqpenia-associated inhibitory activity; PBS,  phosphate-buffered 
salt solution; TF, transferrin. 
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(CFU-c) devoid of CSA-producing  cells and mature granulocytes, CSA-producing  cells depleted 
of mature granulocytes and mature granulocytes alone (2, 17). Cells were separated by a density 
cut  in bovine serum albumin (density,  1.070 g/cm3; osmolarity, 270  mosmol). CFU-c were 
present in the nonadherent low density fraction (<1.070 g/cm  s) and CSA-producing cells were 
found in the adherent low density fraction. Mature granulocytes (90-100%  pure) were present 
in the high density fraction (>1.070 g/urnS). 
Assay Procedures 
A.  CSA PRODUCTION.  Human active CSA was obtained from endogenous marrow CSA- 
producing cells, peripheral blood monoeytes, and placental cells, all of human origin (2,  17, 
23). Human adherent low density blood cells which contained >90% monocytes as judged by 
morphological criteria and histochemical affinity for a naphtyl acetate esterase and neutral red 
were suspended at 2-5  ×  105 cells/ml and allowed to condition McCoys medium (Memorial 
Sloan-Kettering Institute,  N.  Y.)  containing 10%  fetal  calf serum  (FCS)  (Microbiological 
Associates, Walkersville, Md.) with CSA for 2-4 days. 
Murine active CSA was obtained from medium conditioned by WEHI-3 cells,  a  touring 
myelomonocytic leukemia cell line (4,  24),  and from heart  and lung of mice treated  with 
eyclophosphamide.  WEHI-3 cells  were  suspended  at  I-2  ×  l0  s  cells/ml and  allowed  to 
condition medium as above. The entire heart was removed from each treated mouse, rinsed in 
McCoy's medium, sliced into six to eight large parts, and allowed to condition 5 ml of medium 
for 3-4 days.  The intact lung from each treated mouse was also allowed to condition 5 ml of 
medium with CSA. 
Dilutions of test material were placed in the dishes at time zero with the human monocytes 
or WEHI-3 cells or 1 and 2 days after the cells had started to condition the culture medium. 
Human and murine cell conditioned medium were assayed for CSA as in C either undiluted 
or diluted at 0.1  ml before or after dialysis in spectropor membrane tubing (tool  wt cutoff 
~6-8,000 daltons; Spectrum Medical Industries Inc., Los  Angeles)  against  10 mM sodium 
phosphate buffer pH 7.0 (2  ×  100 vol). Conditioned medium was passed through a Millipore 
filter (Millipore Corp., Bedford, Mass.)  and stored at -20°C until assay. 
B.  COLONY.  (>50 cells/clone) and cluster (3-50 cells/clone) formation of bone marrow 
CFU-c stimulated by endogenous CSA-producing cells  (spontaneous assay).  Human bone 
marrow cells depleted of mature granulocytes (density <1.070 g/cm  a) and bone marrow cells 
of mice recovering from c~clophosphamide at a  time when mature granulocytes were absent 
were suspended at 3  X  10  cells in 1 ml of a 0.3% agar culture medium (Difco Laboratories, 
Detroit, Mich.) with enriched McCoy's medium containing 10% heat-inactivated FCS. Inhi- 
bition of human colony formation was assessed by addition of 0.1 ml of various dilutions of test 
material. 
C.  COLONY  AND  CLUSTER FORMATION  OF  BONE  MARROW  CFU-C STIMULATED BY  EXOGENOUSLY 
SUPPLIED CSA.  In the human assay,  1-2  X  105 nonadherent low density bone marrow cells 
(depleted of endogenous CSA-producing cells) per milliliter in 0.3% agar culture medium were 
stimulated by CSA derived from human blood leukocytes in a 0.5% agar feeder layer (prepared 
3-7 days before addition of target cells and test material), or a constant amount of stimulatory 
activity derived from human blood monocyte or human placental cell-conditioned  medium. In 
the mouse assay,  0.5-1.0  ×  105 unseparated or nonadherent mouse bone marrow cells were 
stimulated by murine cell conditioned medium. Dilutions of inhibitory test material were made 
and 0.1 ml added to the culture plates. 
D.  IN vivo INHIBITORY  ASSAY.  5-7-wk old conventionally  outbred female Swiss mice (CD-1, 
Charles River Breeding Laboratories, Inc., Wilmington, Mass.)  and 3-6 mo-old C57B1/6 mice 
(The Jackson Laboratory, Bar Harbor, Maine) were treated with 200 mg cyclophosphamide/kg 
body wt and served as an in vivo model for inhibition  of rebound granulopoiesis as described 
in reference 5. 
E.  ERYTHROID COLONY ASSAYS.  Erythroid colony assays were carried out according to the 
method of Iscove  et  al.  (Friedrich Miescher-Institut, Basel,  Switzerland)  (25,  26).  Human 
unseparated or nonadherent low density bone marrow cells were plated at  1 or 2  X  105/plate 
and murine bone marrow cells  were  plated at  2  ×  105/plate.  Cells were  plated  in alpha 
medium containing  a final concentration of 0.8% methylcellulose, 30% FCS, 1% bovine serum 
albumin, and 1 U/ml of human urinary erythropoietin. The erythropoietin was kindly supplied 1054  LACTOFERRIN, A FEEDBACK INHIBITOR  OF GRANULOPOIESIS 
Flo.  1.  Immunoelectrophoresis  of normal human serum, lactoferrin, and transferrin developed 
against anti-transferrin and anti-laetoferrin antisera. Well  a, normal human serum; well h, purified 
human transferrin; well e, normal human serum; well d, purified human lactoferrin (photograph of 
unstained preparation). 
by Dr. Norman Iscove. Individual colonies were plucked, placed on glass slides, stained with 
benzidine, and counter stained with Wright-Giemsa to confirm the erythroid nature of the 
colonies. 
Culture Conditions and Scoring of In  Vitro Cultures.  In vitro cultures were incubated at 37°C in 
a  humidified atmosphere of 5% CO2 in air. Myeloid colonies (>50 cells) and clusters (3-50 
cells) were scored at days 7-12 for human cells and days 5-7 for mouse cells. Human erythroid 
colony-forming units (CFU-e) and burst-forming units (BFU-e) were scored  at 7 and 14 days, 
respectively.  Murine CFU-e and BFU-e were scored at 2 and 9 days, respectively. 
Statistics.  The probability of differences  between samples was determined with the use of 
the Student's t test. Three to five plates were scored for the CFU-c assay and four to eight plates 
were scored  for the CFU-e and BFU-e assays. In the assay for CSA production, the supernate 
from three to five plates was each assessed separately with three to five agar culture plates 
scored for each conditioned medium plate. The cells from the tissues and organs of each mouse 
were set up separately using five plates per point. The means :t:  1 SEM of each experimental 
point were obtained from the average values of five mice. 
Preparation of Cell-Free Granulocyte Colony InhibitorY Factor (CIF).  Cell extracts were prepared 
by suspending mature granulocytes at concentrations of 1.0-20.0  ×  10  n cells/ml in serum-free 
enriched McCoy's 5A medium and lysing the cells by rapid freezing and thawing (one to three 
times to 0°C). Extracts were passed through a Millipore filter (pore size, 0.45/aM). CIF was also 
obtained when mature granulocytes were allowed to condition serum-free medium for 1-2 days. 
The extracts or conditioned media were frozen and used as needed or subjected to purification 
by uhracentrifugation, DEAE-Sephadex chromatography, sodium dodecyl sulfate (SDS) poly- 
acrylamide gel electrophoresis,  and isoelectric  focusing as previously described (6). 
Agents Used 
ANTISERA.  The purified immunoglobulin  fractions of rabbit anti-human  LF and transferrin 
(TF)  were  obtained from  Dako  Immunoglobulins (Accurate Chemical &  Scientific Corp., 
Hicksville, N. Y.) and goat anti-human LF antiserum (27) was generously supplied by Dr. Jiri 
Mesteky (University of Alabama, Birmingham, Ala.). Anti-LF immunoglobulin  gave a single 
precipitation line after immunoelectrophoresis (Fig.  1) or Ouehterlony double diffusion (not 
shown)  against purified LF and human skim milk but did not cross-react  with purified TF or 
normal human serum. Conversely, anti-TF immunoglobulin  gave a single sharp precipitation 
line against purified TF or normal human serum but did not cross-react  with purified LF. 
Mature granulocyte extracts cross-reacted  with anti-LF but not anti-TF (data not shown). 
Rabbit anti-human Ia antisera prepared as described in (28) was generously supplied by Dr. 
Robert Winchester of Rockefeller University, N. Y. Spontaneous 
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[Io.  2.  The  inhibitory activity of ]actoferrin  enhanced by  increased iron  saturation.  Native 
lactoferrin  is 8% iron saturated. Brackets  represent  :1:1  SEM.  10-15% Fe saturation curve for 
lactoferrin was superimposable  with that of native laetoferrin and is not shown. Sat, saturation. 
Rabbit anti-human fl2-microglobulin was purchased from Dako Immunoglobulins. Rabbit 
anti-human IdA was purchased from Behring Diagnbstics (Somerville, N. J.), and rabbit anti- 
human complement (Ca) and rabbit anti-human a2-macroglobulin were purchased from N. L. 
Cappel Laboratories Inc., (Coehranville, Pa.). The antisera were extensively dialyzed at  4°C 
against phosphate-buffered salt solution (PBS) to remove previously added sodium azide before 
use in the in vitro tests. 1056  LACTOFERRIN,  A  FEEDBACK  INHIBITOR OF  GRANULOPOIESIS 
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Fxo.  3.  Lack  of an inhibitory effect of lactoferrin on exogenously  stimulated colony and"  cluster 
formation of hone marrow cells depleted of the adherent endogenous CSA-producing cells. Blood 
leukocyte feeder layers were 5 days old before plating the target marrow plus lactoferrin. 
Commercial LF, prepared by ammonium sulphate precipitation of human skim milk (29) 
was obtained from Calbiochem (San Diego,  Calif.). LF was purified in this laboratory from 
human skim milk by the method of Johannson (30) as adapted by Queringean, Masson, and 
Heremans (15). Purified human TF was purchased from Behring Diagnostics. 
Bacterial Lipopolysaccharide.  (Salmonella typhosa W0901)  (LPS)  was  purchased  from  Difco 
Laboratories (Detroit, Mich.). 
Iron Removal and Saturation of LF.  Apo-LF was prepared by dialysis at 4°C against 100 vol of 
0.1 M citric acid (31, 32). After 48 h, the protein was dialyzed with two changes against PBS 
at 4°C. 
Iron-Saturated LF and TF.  Iron-saturated LF and TF were prepared in two ways. In the'first 
method, native LF was  dialyzed for  48  h  at 4°C, first  against 500  vol of saturated ferrous 
ammonium sulphate and then against PBS at 4°C (32). In the second method, 10/tl of various 
dilutions of a  10-mM ferric citrate solution were added to three 1-ml samples of LF or TF at 
100 #g protein/ml to yield either fully saturated, partially saturated (~30-45% saturated), or 
poorly saturated (~8% saturated) solutions. The fully saturated LF from the first and second 
methods were equally potent when assayed against CSA production. 
Isoelectric Focusing.  Preformed polyacrylamide gel plates (245  ×  110  x  1 mm) containing 
2.4% wt/vol ampholytes (pH range of 3.5-9.5)  were purchased from LKB (Sweden)  (33). The 
test materials were applied on the gel surface and the gel was focused for -~2 h after which l-cm 
squares were cut along the gel edge from the cathode to the anode. These were each placed in 
1 ml of distilled water overnight and used to measure the pH. The remainder of the gel was cut 
into l-era strips each of which was further cut into 11  l-era squares. Each square was eluted 
overnight in 1 ml of PBS and the eluate dialyzed extensively against PBS. 
Results 
Comparative  Analysis  of the In  Vitro  Action  of CIF and LF on  Colony and Cluster Forma- 
tion.  Conditioned media and extracts from human and murine mature granulocytes 
inhibit spontaneous colony and cluster formation of human and murine bone marrow 
cells by suppressing endogenous CSA production (2). In preliminary experiments it Colonies 
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Fxo.  4.  Medium conditioned by adherent mononuclear blood cells in presence ofCIF, lactoferrin, 
or  transferrin  before  addition  to  target  ceils.  Inhibitory  effect  of lactoferrin  and  CIF  on  the 
elaboration of CSA from adherent mononuclear blood ceils (90%  monocytes). Transferrin had no 
effect on CSA production. 
was noted that native LF (8% iron saturated)  also reduced spontaneous colony and 
cluster  formation  of human  bone marrow cells.  One  of four similar  dose-response 
assays is presented in Fig. 2. Native LF maximally inhibited 71% of colonies (Fig. 2 a) 
and  55%  of total  aggregates  (Fig.  2 b).  The inhibitory activity fell off but  was still 
detectable between 10  -13 and 10  -14 M  for colonies, 10  -12 and 10  -13 M  for colonies and 
clusters, and all activity was lost by 10-a4-10  -t6 M  LF. 
Effect of Iron Saturation on the Action of LF.  It was readily apparent from Fig. 2 and 
four other experiments that  the percent iron saturation  of LF markedly influenced 
inhibitory activity. LF depleted of iron (Apo-LF) was only inhibitory at concentrations 
>  10  -7 M,  but  fully iron-saturated  LF extended  the  dilution  of LF  that  inhibited 
spontaneous colony and cluster formation (to 10  -17 M) and also increased the plateau 
levels of inhibition to 84% and 65% for colonies and total aggregates, respectively. As 
shown  in  Fig.  2  (and  in  three additional  experiments not  shown),  human  TF had 
minimal inhibitory activity (10-34%)  at concentrations >  10  -6 M.  Fully saturating 
TF with iron did not enhance this minimal inhibitory activity. 
Site and Mode of Action of LF.  To determine the mechanism of LF action, two other 
assay  systems  were  employed.  In  the  first,  endogenous  CSA-producing  cells  were 
removed from low density marrow cells by adherence to plastic and the effect of LF 
was monitored on colony and cluster formation of nonadherent  marrow cells stimu- 
lated by exogenous CSA. In the second assay, the effect of LF on CSA production was 
assessed. 
The results of one of four similar experiments using blood leukocyte feeders as a 
source  of exogenous  CSA  is  shown  in  Fig.  3.  LF  (apo  to  fully  iron  saturated)  at 
concentrations between  l0 -~ and  10  -11 M  had no effect on exogenously stimulated 
colony and cluster formation of bone marrow cells depleted of adherent endogenous 
CSA-producing cells. TF at these concentrations also had no influence on the assay 
(data not shown). In six other experiments,  I0-4-I0  -s M  LF had no effect on colony 
and  cluster  formation  of  nonadherent  bone  marrow  cells  stimulated  by  various 1058  LACTOFERRIN,  A  FEEDBACK  INHIBITOR  OF  GRANULOPOIESIS 
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Fla.  5.  Medium  conditioned  by  adherent  mononuclear  blood  cells  in  presence  of lactoferrin 
and/or  bacterial  LPS  before addition  to  target  cells.  LPS  abrogation  of the inhibitory  effect of 
lactoferrin on CSA production. 
dilutions of human placenta-conditioned medium CSA (in the range of 3-150 colonies 
and  10-450  total aggregates). This suggested that  LF was not  acting to inactivate 
performed CSA or to decrease the sensitivity of CFU-c to CSA. 
The capacity of LF to inhibit CSA production was tested by incubating LF with 
human adherent mononuclear blood cells. As shown in Fig. 4, purified CIF and LF 
at  10  -6 and  10  -7 M  suppressed CSA production,  but  TF  at  10  -6 and  10  -7  M  was 
without  effect.  Preincubation  of mononuclear blood cells with  10  -7 M  LF for x~ h 
before washing  reduced  CSA  production  to  the  same extent  as  leaving  LF in  the 
medium through the 3-day conditioning medium period. Both procedures resulted in 
60% inhibition  of CSA production.  The suppressive effect of LF was reversible and 
could be blocked and/or overcome in a concentration-dependent fashion by bacterial 
LPS activation of human adherent mononuclear blood cells. As demonstrated in Fig. 
5, more LPS was needed to overcome the effect of increasing concentrations of LF 
and  vice versa.  0.1  #g  LPS  decreased  the  inhibitory  influence  of LF  but  did  not 
increase CSA production, whereas  I #g of LPS both stimulated CSA production and 
reversed the inhibition.  In another experiment, shown in Table I, in which human 
adherent mononuclear blood cells and murine WEHI-3 cells were exposed to 10  -s M 
LF at day 0 and 1 #g LPS at either day 0, 1, or 2, LPS reversed the inhibitory activity 
of LF. The reversal was total if LPS was added at day 0, partial if LPS was added  1 
day after LF, and nil if added at 2 days. 
Identity of LF and CIF Shown by Isoelectric Focusing.  Laboratory purified  LF cross- 
reacted with anti-LF, but not anti-TF, in the Ouchterlony double-diffusion technique 
and suppressed CSA production by human adherent  mononuclear blood cells (data BROXMEYER,  SMITHYMAN,  EGER,  MEYERS,  AND  DE  SOUSA 
TABLE  I 
Abrogation of lnhibito~  Action of Lactoferrin by Bacterial LPS 
1059 
CFU-c*  %A 
Medium conditioned by human adherent mononuclear cells~ 
Control medium 
Lactoferrin, 10  -s M  (day (3) 
LPS, 1 #g (day 0) 
Lactoferrin,  10  -s M  (day 0)  +  LPS,  1 #g (day 0) 
Lactoferrin, 10  -a M  (day 0)  +  LPS,  1 #g (day 1) 
Lactoferrin,  10  -s M  (day 0)  +  LPS, l p.g (day 2) 
Medium conditioned by WEHI-3 cells~ 
Control medium 
Lactoferrin, t0  -s M  (day 0) 
LPS,  1 #g (day 0) 
Lactoferrin,  10  -a M  (day 0)  +  LPS,  1 #g (day 0) 
Lactoferrin,  10  -s M  (day 0)  +  LPS,  1 #g (day 1) 
76+6 
21  4-  2  -72§ 
111  4-  5  +46§ 
120  ±  5  + 58§ 
48  ±  1  -37§ 
20  ±  3  -74§ 
111  ±  4 
20 ±  2  -82§ 
160  ±  5  +44~ 
141  ±  6  +27§ 
70 ±  3  -37§ 
* Colonies per 1 ×  10  s human nonadherent bone marrow cells stimulated by human cell conditioned 
medium and 1 ×  105 C57B1/6 mouse bone marrow cells stimulated by WEHI-3 cell-conditioned 
medium. 
Human conditioned medium collected after 3 days and WEHI-3 conditioned medium collected 
after 2 days. 
§ Significant change P <  0.05. 
TABLE  II 
Inactivation of CIF with Anti-Lactoferrin, but not with Anti-Transferrin 
Experi-  Antiserum*  Dilution  Test material  Colonies +  %A 
ment  clusters~ 
1  None  McCoy's Medium  201  +  11  - 
None  CIF-Crude§  104  +  4  -48[[ 
None  CIF-Purified§  130 4-  l t  -351l 
Anti-lactoferrin  l0  -2  CIF-Crude  215  -4- 6  +7 
Anti-lactoferrin  10  -2  CIF-Purified  203  ±  7  -1 
None  McCoy's Medium  557  ±  12  - 
None  CIF-Crude  373  4- 5  -331[ 
None  CIF-Purified  357  ±  4  -3611 
Anti-lactoferrin  10  -1  CIF-Crude  554  ±  10  -1 
Anti-lactoferrin  10  -x  CIF-Purified  518  ±  20  -7 
Anti-transferrin  10  -1  CIF-Crude  355  ±  10  -3611 
Anti-transferrin  10  -1  CIF-Purified  377  ±  28  -321[ 
* One part antiserum plus three parts test material were incubated at room temperature for 2-3 h  before 
placing into test assay. The antiserum itself had no effect on the assay. 
:~ Colonies and clusters per 3  X  105 light density human bone marrow cells stimulated by endogenous CSA 
(spontaneous assay) were scored after 10 days of incubation. Results were similar for colonies. 
§ Crude CIF is initial mature granulocyte extract and purified CIF is extract subjected to DEAE Sephadex 
chromatography, SDS polyacrylamide gel electrophoresis, and isoelectric focusing as in reference 6. 
]] Significant change, P <  0.05. 
not  shown).  This  fraction,  commercial  LF,  and  purified  CIF  were  subjected  to 
isoelectric  focusing  and  the  capacities  of these  three  materials  to  suppress  CSA 
production were compared. Maximum inhibitory activity for the three preparations 
were  found  in  the  same area which  corresponded  to a  pH range of 6.5  (data not 
shown), a pH value consistent with that determined by others for LF (14,  16). 1060  LACTOFERRIN,  A  FEEDBACK  INHIBITOR  OF  GRANULOPOIESIS 
TABL~  III 
Specificity of the Anti-Lactoferrin* Inactivation of CIF and Lactoferrin 
Colonies and 
Antiserum~  Test material  clusters§  %A 
None 
None 
None 
None 
Anti-lactoferrin 
Anti-lactoferrin 
Anti-lactoferrin 
Anti-lactoferrin 
Anti-lactoferrin 
Anti-lactoferrin 
Anti-lactoferrin 
rin)** 
Anti-lactoferrin 
tin)** 
Anti-lactoferrin 
rin)** 
McCoy's medium  258  ±  9  - 
CIF-Crude[[  130 ±  3  -50¶ 
CIF-Purifiedl[  112 ±  10  -57¶ 
Lactoferrin, 1/xg/ml  129 :t:  10  -50¶ 
(unabsorbed)  CIF-Crude  252  ±  19  -2 
(unabsorbed)  CIF-Purified  259 ±  4  0 
(unabsorbed)  Lactoferrin, 1/~g/ml  274  :t:  13  +6 
(absorbed with lactoferrin)** 
(absorbed with lactoferrin)** 
(absorbed with lactoferrin)** 
(preincubated with  transfer- 
(preincubated with transfer- 
(preincubated with  transfer- 
CIF-Crude  124 ±  15  -52¶ 
CIF-Purified  113 ±  7  -56¶ 
Lactoferrin, 1/~g/ml  108 ±  6  -58¶ 
CIF-Crude  265  ±  8  +3 
CIF-Purified  250 ±  10  -3 
Lactoferrin, 1/~g/ml  248  ±  13  -4 
* Rabbit IgG anti-human lactoferrin; the antiserum (absorbed and unabsorbed) had no effect  on the 
assay. 
:~ One part antiserum (10  -1  dilution)  to three parts test material were  incubated for 2  h  after a  2 h 
absorption with lactoferrin or transferrin and then assayed. 
§ All spontaneous aggregates >  3 cells  (colonies  and clusters)  are shown but results were similar for 
spontaneous colonies  (>50 cells aggregate) alone. 
[I Crude CIF is initial mature granulocyte extract and purified CIF is extract subjected to DEAE Sephadex 
chromatography, sodium dodecyl sulfate polyacrylamide gel electrophoresis, and isoelectric  focusing as 
in reference 6. 
¶ Significant change, P<  0.05. 
** 25/zg Lactoferrin were incubated with 0.5 ml of a  1/10 dilution of anti-lactoferrin because a titer of 500 
/~g/ml yields 100% absorption on the basis of Sewell test (personal communication, Dakopatts, Denmark). 
As a control, 25 #g transferrln was incubated with 0.5 ml of 1/10 dilution of anti-lactoferrin. When 15 
#g lactoferrin were incubated with 0.5 ml of a  1/10 dilution of antiqactoferrin, it did not absorb out the 
effect  of the  anti-lactoferrin which was  still  able  to completely inactivate the  inhibitory effects  of 
lactoferrin and CIF. 
Specificity  Controls 
EFFECT  OF  ANTI-LF  AND  OTHER  NONRELATED  ANTISERA.  As shown  in Table II, the 
purified  immunoglobulin  fraction  of rabbit  anti-human  LF  (at  10  -1  and  10  -2  dilu- 
tions) inactivated  the effect of the crude and  purified CIF, whereas a  10  -1 dilution of 
the purified  immunoglohulin  fraction of rabbit  anti-human  TF  had  no influence on 
CIF.  Rabbit  anti-LF  also inactivated  the influence of LF on CSA  production  (Table 
III). The  influence of anti-LF  on CIF was blocked by prior absorption  of the anti-LF 
with neutralizing concentrations  of LF, but TF  did not block the inactivation  of CIF 
by rabbit  anti-LF. Goat  anti-human  LF antiserum  at a  10  -a dilution inactivated  the 
CSA  inhibitory effects of 10  -s/~g LF and  a  10  -2 dilution of the purified CIF, whereas 
a  10  -4 dilution of goat anti-LF  did not inactivate  10  -6 #g LF but partially inactivated 
10  -l°/zg LF  (data not shown). Normal  goat serum  did not inactivate LF or CIF. 
In  further  attempts  to  determine  the  specificity  of  inactivations,  various  other BROXMEYER,  SMITHYMAN, EGER,  MEYERS, AND De SOUSA 
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Human Lactoferrin and CIF do not Inhibit E~ythropoietin-Dependent Bone Marrow Etythroid 
Colony Formation 
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Test material  CFU-e  %A*  BFU-e  %A* 
Human bone marrow cells 
Medium  130 4-  19  36 4- 2 
Native lactoferrin,  10  -7 M  132 4- 6  + 1  36 -4 2  0 
Saturated lactoferrin,  10  -7 M  119 4-  12  -8  36 4- 3  0 
Purified CIF  119 4-  7  -8  35  4- 4  -3 
Crude CIF  132 +  7  + 1  33  4- 3  -8 
Intact PMN:~, 1 ×  10  s cells  1  I0 4-  11  -  15  35 4-  1  -3 
BDF mouse bone marrow cells 
Medium  85 4- 9  26:1:2 
Native lactoferrin,  10  -7 M  79 4- 5  -7  25  4- 2  -4 
Saturated lactoferrin, 10-TM  83 +  6  -2  25  4- 2  -4 
Purified CIF  83 4- 9  -2  23  4- 3  -12 
Crude CIF  73 4- 4  -14  25 "4- 2  -4 
Intact PMN, 1 X  106 cells  103 ±  8  +21  24 4- 2  -8 
C57 BL/6 Mouse bone marrow cells 
Medium  86 4- 5  23  4-  1 
Native lactoferrin,  10  -7 M  90 +  5  + 5  22  4- 3  -4 
Saturated lactoferrin, 10-7M  81  4-  7  -6  23  4- 2  0 
Purified CIF  79:1:4  -8  22  4- 2  -4 
Crude CIF  80 4- 4  -6  22 4- 2  -4 
Intact PMN, 1 X  106 cells  79 -4- 6  -8  22  4- 2  -4 
* None of the changes  were significant,  P >  0.05. 
PMN, polymorphonuclear neutrophils -- mature granulocytes. 
antisera  were  tested.  None  of the  following  antisera  inactivated  LF  or  CIF:  anti- 
human  Ia  1/40,  anti-human  fl2-microglobulin  (10-x),  anti-human  az-macroglobulin 
(10-1),  anti-human  IgA (10 -1)  and anti-human  complement  (Ca)  (10-1). 
EFFECT  OF  ANTI-LF  ON  OTHER  INHIBITORS  OF  CFU-C  WHICH  DO  NOT  SUPPRESS CSA 
PRODUCTION.  In further  specificity tests,  rabbit  anti-LF had  no influence on inhibi- 
tory activities which  can  be distinguished  from  CIF  by their cells of derivation  and 
action.  One,  termed  leukemia-associated  inhibitory  activity  (LIA),  is  derived  from 
leukemic  bone  marrow  and  blood  cells  and  inhibits  colony  formation  by  normal 
CFU-c but not leukemic CFU-c (34, 35). The other, neutropenia-associated  inhibitory 
activity  (NIA),  is  derived  from  bone  marrow  and  blood  cells  of  patients  with 
neutropenia  of varying etiologies and  inhibits colony formation of normal,  leukemic 
and  neutropenic  CFU-c  (36).  LIA and  NIA  do  not  influence  CSA  production  (34, 
36). 
EFFECT  OF  LF  AND  CIF  ON  ERYTHROID  COLONY  FORMATION.  CIF,  LF,  and intact 
mature  granulocytes  were  assayed  for  their  influence  on  erythropoietin-dependent 
CFU-e  and  BFU-e  cells.  As  shown  in  Table  IV,  CFU-e  and  BFU-e  from  human 
marrow and BDF and C57B1/6 mouse marrow were not inhibited. These results have 
been  repeated  on  three other human  marrow  samples  and  one other mouse sample. 
EFFECT  OF  LF  ON  MURINE  REBOUND GRANULOPOIESIS  AND  CSA  PRODUCTION  IN 
VlVO.  Having  demonstrated  that  LF was  identical  to  CIF  in  its  in  vitro  action,  it 
was important  to substantiate  this finding in vivo. Thus, a  recently published  in vivo 
assay which depends on rebound  granulopoiesis  to detect  inhibition by administered 1062  LACTOFERRIN,  A  FEEDBACK INHIBITOR  OF GRANULOPOIESIS 
TASLZ  V 
Inhibition of Rebound C,  ranulopoiesis in Cyclophosphamide-Treated Mice by Lactoferrin * 
Bone marrow  Bone marrow 
Test material  CFU-c; no added  %A  CFU-c; added  %A 
CSA*  CSA* 
CDI Mice 
McCoy's medium  345  ±  85 
Transferrin  555  ±  122 
Lactoferrin  87  +  33 
C57B1/6 Mice 
McCoy's medium  ND  H 
Transferrin  ND 
Lactoferrin  ND 
-  3,007 ±  762  - 
+60  2,258 ±  682  -25 
-70§  613  ±  225  -80§ 
8,422 ±  525 
ND 
4,853 ±  871  -42§ 
* CDFI and C57B1/6 mice were pretreated with 200 mg cyclophosphamide/kg  body wt on day 0. 
Each mouse then received two i.v. injections  (total of 1.2 ml) each on days 1 and 2. Each 0.l ml 
=  1 #g lactoferrin or transferrin Mice were sacrificed  on day 3 ='12 h  after the last  injection. 
Results are given as absolute number of s~ontaneous or stimulated colony forming cells per femur 
and expressed as mean ±  1 SEM ×  10-  for five mice per group. 
No added CSA and added CSA refer to the cultures  after cells are removed from the mice. 
§ %A, Percent significant  change (P <  0.05) from MeCoy's medium. 
][ ND, Not done. 
TABLE VI 
Colony-Stimulating Activity in Medium Conditioned by Heart and Lung of Control, Lactoferrin- and 
Transferrin- Treated Cyclophosphamide Mice 
Conditioned  Treatment of con- 
Mouse strain 
medium source  ditioned media 
Colony-stimulating Activity* of mice treated 
with 
Media  Transferrin  Lactoferrin 
Lung 
Heart 
CDa  Undialyzed  128  ±  9  120 ±  13  40  +  3 
(-6)~  (-69)§ 
CDI  Dialyzed  174  ±  10  163  ±  15  25  ±  3 
(-6)  (-86)§ 
C57B1/6  Undialyzed  145  4-  20  -  51  ±  6 
(-65)§ 
C57B1/6  Dialyzed  124  ±  10  -  25  ±  3 
(-80)§ 
CDt  Undialyzed  68  ±  5  82  ±  11  16  ±  4 
(+21)  (-76)§ 
C57B1/6  Undialyzed  73  ±  12  -  10  ±  5 
(-86)§ 
* Colony-stimulating activity expressed as number ofCFU-c ±  1 SEM/1  ×  105 mouse bone marrow cells 
stimulated by 0.1 ml of a  1:2 dilution of conditioned media. 
:[: Number in parentheses designates the percent change from media control. 
§ Percent significant  change (P <  0.05) from media control. 
CIF  (5)  was utilized to test the in vivo effect of LF. Three days after i.p. injection of 
200 mg cyclophosphamide/kg  body wt, mature  granuloeytes are depleted from mice 
whereas  absolute  numbers  of  CFU-c  and  net  endogenous  CSA  production  are 
increased in the bone marrow  (5). Administration of 20 #g human  LF during the  1st 
and  2nd  days  after  cyclophosphamide  dampened  rebound  granulopoiesis  in  the BROXMEYER,  SMITHYMAN,  EGER,  MEYERS,  AND  DE  SOUSA  1063 
marrows of CDx and C57B1/6 mice as assessed on the 3rd day after cyclophosphamide 
(Table V). LF substantially decreased total marrow CFU-c numbers as detected by 
adding  a  source  of exogenous CSA  to  the  marrow  cells  in  culture.  Inhibition  of 
marrow CFU-e numbers was more pronounced in CD1 (80%) than in C57B1/6 mice 
(42%). Net endogenous marrow CSA production, as demonstrated in cultures without 
exogenously added CSA, was also substantially reduced. 20 #g of TF did not have a 
significant influence in these assays. Heart and lung cells removed from both mouse 
strains injected with LF produced 65-86% less CSA than control mice injected with 
McCoy's media or TF  (Table VI). This was substantiated  by assaying dialyzed as 
well as undialyzed conditioned media. 
Discussion 
It has been suspected that LF might have activities in addition to its capacity to act 
as a bacteriostatic agent (37). We have now presented evidence indicating that LF is 
identical to CIF and as such has the additional capacity to regulate CSA production 
in vitro and granulopoiesis in vivo. 
Three experimental approaches were used to identify LF as the granulocyte CIF: 
the first was to demonstrate that LF acted in vitro and in vivo in a manner analogous 
to CIF;  the second was to demonstrate that  the inhibitory activity was localized in 
the same region after separation of LF and CIF by isoelectric focusing; and the third 
was to demonstrate that anti-LF antisera could inactivate the action of both CIF and 
LF. 
LF,  as  reported  earlier  for  CIF  (2),  and  as  documented  here,  inhibits  CSA 
production by interacting with monocytes and marcrophages but does not decrease 
the sensitivity of the granulocyte progenitor cells (CFU-c) to CSA nor does it inactivate 
CSA.  Significant inhibition of CSA production was attained by  10  -1. M  native LF 
(8% iron saturated). This effect was dependent on the iron saturation of LF molecules. 
Apo-LF was only minimally active at  concentrations >10 -6  M  whereas  fully iron- 
saturated LF samples were active at  10-17-M concentrations. The greater inhibitory 
activity noted with increased iron saturation of LF probably reflects further binding 
of  lactoferrin  to  monocytes  and  macrophages.  The  capacity  of  LF  to  bind  to 
macrophages is enhanced by iron saturation of the molecules (21, 22), a phenomenon 
believed to result from a conformational change of the protein upon iron binding (16, 
21). Failure to reduce CSA production to zero levels is most likely related to the fact 
that monocytes and macrophages contain performed CSA (2) and that already formed 
but not yet released CSA is not affected by LF. The inhibitory effect of LF was fully 
reversed by bacterial LPS if LPS was added simultaneously with the LF, and partially 
reversed if LPS was added 24 h  after LF. The mechanisms of these interactions are 
not clear but may relate to the iron-binding capacity of LPS (38, 39)  because it has 
been reported that 1 mg LPS binds 4.8-5.2/~g of iron (38). It has been postulated that 
mature  granulocytes limit  CSA  production by eliminating bacteria  (40),  however, 
mature granulocytes in the presence of bacterial products and in response to phago- 
cytic challenge release large quantities of their intracellular contents of LF (22, 41) 
and suppression of CSA production in these circumstances is probably mediated via 
LF. 
The interesting correlation between iron content and activity illustrates how one 
molecule can have two distinct  but  closely related functions. LF has bacteriostatic 1064  LACTOFERRIN,  A  FEEDBACK  INHIBITOR  OF  GRANULOPOIESIS 
and bacteriocidal activity only in the apo or native form (32, 42-46)  whereas fully 
saturated  LF  is  most  effective and  apo-LF  is  least  effective in  suppressing  CSA 
production. Each mature granulocyte (polymorphonuclear neutrophil) contains 3-6 
pg of LF (14, 47-49); this implies that there is enough LF in one mature granulocyte 
to inhibit CSA production of >200,000 monocytes by >60%. If, as suggested earlier, 
neutrophils act as exocrine cells (50) a regulatory mechanism of granulopoiesis can be 
envisaged  as  follows:  native  LF  contained  in  the  secondary  granules  of mature 
granulocytes (47, 51) leaves the cell, possibly in response to specific stimuli; and with 
an  iron  association  constant  of 3  ×  10  z8  (16)  binds  iron  from  the  serum,  thus 
facilitating its capacity to bind to specific receptor sites on monocytes and  macro- 
phages.  This  then  results  in  greater  suppression  of CSA  production.  It  has  been 
calculated that milligram quantities of LF are produced per day by granulocytes (52). 
This figure, added to the specific activity of LF in vitro and the microgram quantities 
needed  for  in  vivo  activity  argue  strongly  for  a  physiological  role  for  LF  in  the 
regulation of granulopoiesis. 
Further  studies  of the  mechanisms  involved  in  this  regulatory  process  are  in 
progress. The identification of CIF as LF allows for more detailed studies in vitro and 
in vivo using purified and labeled molecules. With these molecules it will be possible 
to characterize the postulated role of LF in cell traffic (7, 8). In addition, it will now 
be possible to define more precisely the nature of feedback abnormalities associated 
with myelogenous leukemia and myelodysplasia. We have shown that CSA-producing 
cells of patients with chronic myelogenous leukemia are less responsive than normal 
to suppression by CIF  (3).  This phenomenon which may relate to the iron-binding 
capacity of patient LF or to altered or deficient LF-membrane receptors on patient 
monocytes and macrophages is under investigation. 
Summary 
Lactoferrin (LF), the iron-binding protein present in the specific granules of mature 
granulocytes has been identified as colony inhibitory factor (CIF) which suppresses 
granulocyte--macrophage colony stimulating  activity  (CSA)  production by mono- 
cytes and macrophages in vitro and rebound granulopoiesis in vivo. Separation of LF 
and  CIF  by  isoelectric focusing confirmed  that  the  regions  of inhibitory activity 
corresponded in  both  to  a  pH  of ---6.5. In  addition,  the  purified  immunoglobulin 
fraction of rabbit  anti-human  LF antiserum,  but  not  rabbit  anti-transferrin  (TF), 
inactivated the capacity of LF and CIF to inhibit CSA production, an effect blocked 
by prior incubation of anti-LF with neutralizing concentrations of LF. Suppression of 
CSA production correlated with the iron-saturation of LF; apo-LF (depleted of iron) 
was only active at concentrations >10 -7 M, native LF (8% iron saturated) was active 
at  10  -Is M,  and  fully iron-saturated LF inhibited at  10  -17  M.  Suppression of CSA 
production occurred within a 1/2-h preincubation period with human blood monocytes 
but was reversed by bacterial lipopolysaccharide (LPS). This reversal was dependent 
on the relative concentrations of LF to LPS. Serum TF, a biochemically similar iron- 
binding protein which is antigenically distinct from LF, was only minimally active at 
concentrations >10  -6 M.  LF did not inhibit exogenously stimulated human  granu- 
locyte and macrophage colony-forming cells or erythropoietin-dependent human or 
murine erythroid colony- or erythroid burst-forming cells. Microgram quantities of 
LF acted in vivo to inhibit rebound granulopoiesis and CSA production in CDx and BROXMEYER,  SMITHYMAN,  EGER,  MEYERS, AND  DE SOUSA  I065 
C57B1/6 mice pretreated with cyclophosphamide. These results strongly implicate LF 
as a  physiological regulator of granulopoiesis. 
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